Task: Answer the multiple-choice question.
Query: Which drug has a -20.179% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a Cc1ccc(CN2CCC(=O)N2)cc1
b CC(NC(=O)C(=O)N1CCCCC1)C(c1cccs1)N1CCN(C)CC1
c Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccc(Cl)cc1Cl
Answer: c. Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccc(Cl)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccc(Cl)cc1Cl
Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccc(Cl)cc1Cl
2-(2-methyl-5-nitroimidazol-1-yl)ethyl 2,4-dichlorobenzoate